Cell and Bioscience
Scope & Guideline
Unlocking the Secrets of Life at the Cellular Level
Introduction
Aims and Scopes
- Cellular Mechanisms and Signaling Pathways:
Research articles often explore intricate signaling pathways and cellular mechanisms, including the role of various proteins, RNA modifications, and metabolic processes in health and disease. - Stem Cell Biology and Regenerative Medicine:
The journal frequently publishes studies on stem cell biology, differentiation, and their therapeutic applications in regenerative medicine and tissue engineering. - Cancer Biology and Therapeutics:
A significant portion of the research focuses on cancer biology, examining tumor biology, metastasis, and exploring novel therapeutic strategies and biomarkers. - Neuroscience and Neurodegenerative Diseases:
The journal addresses various aspects of neuroscience, including neural development, neuroinflammation, and neurodegenerative diseases, contributing to a better understanding of brain-related disorders. - Microbiology and Infectious Diseases:
Research on host-pathogen interactions, immune responses, and the development of therapeutic interventions against infectious diseases is a prominent theme. - Metabolism and Disease:
Studies related to metabolic disorders, their cellular mechanisms, and potential therapeutic interventions are also key areas of focus.
Trending and Emerging
- RNA Modifications and Epitranscriptomics:
There is a growing emphasis on the role of RNA modifications, particularly m6A and other epitranscriptomic changes, in regulating gene expression and their implications in various diseases, including cancer and neurodegenerative disorders. - Microbiome and Host Interactions:
Research exploring the interplay between the microbiome and host health is on the rise, particularly its influence on metabolic diseases, immune responses, and cancer progression. - Organoid Models for Disease Modeling:
The use of organoid technology is increasingly prominent, providing innovative platforms for studying disease mechanisms and testing therapeutic interventions in a more physiologically relevant context. - Immunotherapy and Cancer Immunology:
Publications focusing on the mechanisms of immunotherapy, including the role of immune checkpoints and the tumor microenvironment, are trending as researchers seek to enhance treatment efficacy. - Metabolic Reprogramming in Cancer:
Emerging studies are increasingly focusing on the metabolic pathways in cancer cells, exploring how metabolic reprogramming contributes to tumorigenesis and resistance to therapies. - Gene Editing Technologies and Applications:
The application of CRISPR/Cas9 and other gene editing technologies is gaining traction, with research exploring their potential in therapeutic contexts and the ethical implications surrounding their use.
Declining or Waning
- Basic Mechanisms of Epithelial-Mesenchymal Transition (EMT):
Although EMT has been a significant area of study in cancer biology, the frequency of publications focusing solely on the mechanistic aspects of EMT appears to be decreasing, possibly due to a shift towards more integrative approaches that encompass broader cellular interactions. - Traditional Pharmacological Approaches:
There is a noticeable reduction in studies highlighting traditional pharmacological interventions, as the journal's focus is increasingly leaning towards innovative therapies, including gene editing and personalized medicine. - In Vitro Models of Disease:
The use of conventional in vitro models is becoming less prominent, as researchers are moving towards more complex and physiologically relevant models such as organoids and 3D cultures. - Single-Cell Analysis Techniques:
While single-cell technologies have gained significant attention, the specific focus on traditional single-cell sequencing methods is waning, with a greater emphasis now on integrating these techniques with spatial transcriptomics.
Similar Journals
MOLECULAR MEDICINE
Elevating the Standards of Peer-Reviewed ScienceMOLECULAR MEDICINE, published by SPRINGER, is a leading scholarly journal dedicated to advancing the fields of genetics and molecular biology with a focus on clinical applications. Since its inception in 1994, it has evolved to become a pivotal platform for disseminating innovative research findings, achieving a remarkable Q1 ranking in multiple categories, including Genetics, Molecular Biology, and Molecular Medicine as of 2023. Featuring an Open Access model since 2000, the journal ensures that cutting-edge research is freely available to the global scientific community, facilitating collaboration and knowledge exchange. With a commitment to high-quality peer-reviewed content, MOLECULAR MEDICINE serves as an essential resource for researchers, healthcare professionals, and students seeking to stay at the forefront of molecular research and its implications for medical science. For those interested in contributing to or accessing vital research in this dynamic field, MOLECULAR MEDICINE stands out as a premier choice.
Biology Direct
Advancing biological knowledge without barriers.Biology Direct is a leading open-access journal published by BMC, dedicated to disseminating groundbreaking research in the fields of biological sciences. Since its inception in 2006, the journal has emerged as a pivotal platform for scholars, researchers, and practitioners, providing unrestricted access to high-quality, peer-reviewed articles that cover a wide spectrum of topics, including biochemistry, ecology, and applied mathematics. With an impressive ranking in the first quartile across multiple scientific categories, including Agricultural and Biological Sciences and Biochemistry, Genetics, and Molecular Biology, Biology Direct is recognized for its rigorous standards and impactful contributions within the academic community. The journal's open-access model ensures that research findings reach a global audience, fostering collaboration and innovation. Researchers and students looking to stay ahead in the rapidly evolving biological sciences will find Biology Direct an invaluable resource for knowledge and insight.
FASEB BioAdvances
Connecting Researchers Through Open Access ScienceFASEB BioAdvances, published by WILEY, is an esteemed open-access journal dedicated to advancing the fields of biochemistry, molecular biology, and physiology. Since its inception in 2019, the journal has rapidly established a significant presence within the academic community, boasting an impressive impact factor reflective of its Q2 and Q3 standings across various categories, including Biochemistry, Genetics and Molecular Biology, Cancer Research, Molecular Medicine, and Physiology. The journal aims to disseminate high-quality research and innovative findings to enhance the understanding of biological processes, making it a vital resource for researchers, professionals, and students alike. With its commitment to open access, FASEB BioAdvances ensures that groundbreaking research is available to a global audience, facilitating collaboration and exploration in these rapidly evolving scientific domains.
BIOSCIENCE REPORTS
Advancing the Frontiers of Life SciencesBIOSCIENCE REPORTS, published by Portland Press Ltd, is a prestigious journal dedicated to advancing the fields of biochemistry, biophysics, cell biology, and molecular biology. Founded in 1981, the journal has established itself as a vital resource for researchers and professionals, boasting a significant impact factor and high rankings within its categories, including Q2 in Biochemistry and Q1 in Biophysics as of 2023. The journal’s commitment to high-quality, peer-reviewed research ensures that it remains an influential platform for the dissemination of cutting-edge scientific findings. While it operates under a traditional subscription model, it offers various access options to accommodate the needs of the scientific community. With ongoing publication through 2024, BIOSCIENCE REPORTS continues to play a crucial role in shaping discussions in the life sciences and fostering innovative research in biology.
FEBS Journal
Pioneering Discoveries in Life SciencesFEBS Journal is a prestigious, peer-reviewed publication dedicated to advancing the field of biochemistry, cell biology, and molecular biology. Published by WILEY in the United Kingdom, this journal boasts an impressive impact factor and ranks in the top quartile (Q1) across multiple relevant categories, including Biochemistry, Cell Biology, and Molecular Biology, reflecting its significant contribution to scientific research. With an ISSN of 1742-464X and an E-ISSN of 1742-4658, the FEBS Journal publishes original research and comprehensive reviews that push the boundaries of knowledge and innovation in the biosciences. As a vital resource for researchers, professionals, and students alike, the journal offers Open Access options, ensuring that cutting-edge discoveries are accessible to a broad audience. With a publication history converging from 2005 to the present and a robust emphasis on high-quality scholarly work, the FEBS Journal remains an essential platform for the dissemination of significant findings and advancements in the life sciences.
DNA AND CELL BIOLOGY
Unraveling the Mysteries of DNA and Cell DynamicsDNA AND CELL BIOLOGY, published by Mary Ann Liebert, Inc, is a distinguished journal in the realms of cell biology, genetics, and molecular biology, holding a notable position in its Q3 and Q2 quartile rankings across multiple academic categories as of 2023. With an ISSN of 1044-5498 and an E-ISSN of 1557-7430, this journal has been a pivotal platform for the dissemination of cutting-edge research since its inception in 1990, extending its coverage through 2024. Situated in the United States, the journal offers high-quality peer-reviewed articles, exploring significant advancements in biological sciences while fostering interdisciplinary collaborations within the research community. Though it currently does not offer open access, subscribed institutions and individual readers benefit from its rich repository of knowledge. The journal's rigorous standards and impactful content make it an essential resource for researchers, professionals, and students alike, aiming to stay at the forefront of discoveries influencing DNA and cellular dynamics.
BMC Molecular and Cell Biology
Connecting researchers through groundbreaking discoveries.BMC Molecular and Cell Biology is a forward-thinking open-access journal published by BMC, specializing in the vital fields of molecular biology and cell biology. Since its inception in 2019, the journal has carved a niche for itself, ranking in the Q3 quartile in both Cell Biology and Molecular Biology categories as of 2023. With an ISSN of N/A and an E-ISSN of 2661-8850, the journal provides a platform for groundbreaking research, high-quality reviews, and innovative methodologies. Situated in the United Kingdom, BMC Molecular and Cell Biology promotes a diverse range of studies, addressing fundamental questions in biology that resonate with both experts and new researchers alike. The journal's commitment to open access ensures that valuable findings are readily available to the global scientific community, fostering collaboration and knowledge-sharing across disciplines. Researchers aiming to contribute to the field of cell and molecular biology will find this journal an indispensable resource for both publishing and staying informed on the latest advances.
LIFE SCIENCES
Connecting researchers to groundbreaking discoveries in life sciences.LIFE SCIENCES, published by PERGAMON-ELSEVIER SCIENCE LTD, is an esteemed international journal that has been advancing the field since its inception in 1962. With an ISSN of 0024-3205 and an E-ISSN of 1879-0631, it serves as a critical forum for researchers, professionals, and students within the realms of biochemistry, genetics, molecular biology, medicine, and pharmacology. Currently ranked in the Q1 category across multiple disciplines, including a remarkable 2nd rank in General Pharmacology, Toxicology, and Pharmaceutics, the journal maintains a prestigious position in academic circles, evidenced by its high impact factor and significant percentile ranks. While LIFE SCIENCES is not an open-access journal, it remains dedicated to publishing high-quality, peer-reviewed research that pushes the boundaries of knowledge and fosters innovation. With converged research interests leading into 2024, LIFE SCIENCES continues to be a pivotal resource for the dissemination of influential findings, making it an indispensable tool for those engaged in the life sciences.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
Advancing the Frontiers of Respiratory ScienceThe AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, published by the esteemed American Thoracic Society, is a premier platform dedicated to advancing knowledge in the fields of pulmonary and respiratory medicine, cell biology, and clinical biochemistry. With an impressive impact factor and recognition as a Q1 journal in multiple categories for 2023, it ranks among the top tier of scholarly publications, evidencing its influence and contribution to the scientific community. Since its inception in 1989, the journal has provided a critical forum for researchers and professionals to disseminate innovative findings and pivotal reviews, driving forward the frontiers of respiratory biology. While the journal currently operates under traditional access mechanisms, it seeks to bridge gaps in research by presenting high-quality articles that address vital health challenges. As a key resource for both established researchers and emerging scholars in molecular biology and respiratory science, this journal plays a pivotal role in shaping the future of respiratory health advancements.
MOLECULAR AND CELLULAR BIOCHEMISTRY
Unraveling the Mysteries of Molecular BiologyMOLECULAR AND CELLULAR BIOCHEMISTRY, an esteemed journal published by SPRINGER, serves as a prominent platform in the fields of biochemistry and molecular biology. With a history of dissemination since 1973, this journal has made significant contributions to the understanding of biochemical processes at the molecular level. The MOLECULAR AND CELLULAR BIOCHEMISTRY journal focuses on a myriad of topics including but not limited to cellular biochemistry, clinical biochemistry, and interdisciplinary approaches in medicine, boasting a commendable categorization in the 2023 Scopus ranks where it falls under Q3 in Cell Biology, Q2 in Clinical Biochemistry, Q1 in Medicine (miscellaneous), and Q2 in Molecular Biology. Although the journal is not open access, it provides access options through institutional subscriptions, making valuable research accessible to a wider audience. With its rigorous peer-review process and high impact within the scientific community, this journal aims to advance knowledge and stimulate exploration in biochemical research, making it essential reading for researchers, professionals, and students alike.